Literature DB >> 17070046

Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptors.

Stephen Hanessian1, Guillaume Charron, Andreas Billich, Danilo Guerini.   

Abstract

Constrained azacyclic analogues of FTY720 were prepared starting with d- and l-pyroglutamic acids. One enantiomer was shown to be a substrate for sphingosine kinase 2, being phosphorylated 4-fold more efficiently than FTY720. Among the corresponding phosphates, two were found to have unusual specificity in binding to S1P receptors: while being inactive on S1P1 and S1P3, they acted as potent agonists on S1P4 and S1P5. The phosphates may be useful to explore the biology and binding site of these receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070046     DOI: 10.1016/j.bmcl.2006.10.014

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

Review 1.  Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.

Authors:  Dong-Soon Im
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

2.  Pulmonary endothelial cell barrier enhancement by novel FTY720 analogs: methoxy-FTY720, fluoro-FTY720, and β-glucuronide-FTY720.

Authors:  Sara M Camp; Eddie T Chiang; Chaode Sun; Peter V Usatyuk; Robert Bittman; Viswanathan Natarajan; Joe G N Garcia; Steven M Dudek
Journal:  Chem Phys Lipids       Date:  2015-08-10       Impact factor: 3.329

3.  Discovery, synthesis and SAR analysis of novel selective small molecule S1P4-R agonists based on a (2Z,5Z)-5-((pyrrol-3-yl)methylene)-3-alkyl-2-(alkylimino)thiazolidin-4-one chemotype.

Authors:  Mariangela Urbano; Miguel Guerrero; Subash Velaparthi; Melissa Crisp; Peter Chase; Peter Hodder; Marie-Therese Schaeffer; Steven Brown; Hugh Rosen; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2011-09-20       Impact factor: 2.823

4.  Synthetic analogs of FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] differentially regulate pulmonary vascular permeability in vivo and in vitro.

Authors:  S M Camp; R Bittman; E T Chiang; L Moreno-Vinasco; T Mirzapoiazova; S Sammani; X Lu; C Sun; M Harbeck; M Roe; V Natarajan; J G N Garcia; S M Dudek
Journal:  J Pharmacol Exp Ther       Date:  2009-07-10       Impact factor: 4.030

5.  Azacyclic FTY720 Analogues That Limit Nutrient Transporter Expression but Lack S1P Receptor Activity and Negative Chronotropic Effects Offer a Novel and Effective Strategy to Kill Cancer Cells in Vivo.

Authors:  Bin Chen; Saurabh G Roy; Ryan J McMonigle; Andrew Keebaugh; Alison N McCracken; Elizabeth Selwan; Rebecca Fransson; Daniel Fallegger; Andrea Huwiler; Michael T Kleinman; Aimee L Edinger; Stephen Hanessian
Journal:  ACS Chem Biol       Date:  2015-12-14       Impact factor: 5.100

Review 6.  Sphingosine 1-phosphate chemical biology.

Authors:  Kevin R Lynch; Timothy L Macdonald
Journal:  Biochim Biophys Acta       Date:  2008-06-25

7.  Design, synthesis and anticancer activity of constrained sphingolipid-phenoxazine/phenothiazine hybrid constructs targeting protein phosphatase 2A.

Authors:  Jean-Baptiste Garsi; Vito Vece; Lorenzo Sernissi; Catherine Auger-Morin; Stephen Hanessian; Alison N McCracken; Elizabeth Selwan; Cuauhtemoc Ramirez; Amogha Dahal; Nadine Ben Romdhane; Brendan T Finicle; Aimee L Edinger
Journal:  Bioorg Med Chem Lett       Date:  2019-07-19       Impact factor: 2.823

8.  Design, Synthesis, and Anti-leukemic Activity of Stereochemically Defined Constrained Analogs of FTY720 (Gilenya).

Authors:  Rebecca Fransson; Alison N McCracken; Bin Chen; Ryan J McMonigle; Aimee L Edinger; Stephen Hanessian
Journal:  ACS Med Chem Lett       Date:  2013-10-10       Impact factor: 4.345

9.  FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology.

Authors:  Kunitomo Adachi; Kenji Chiba
Journal:  Perspect Medicin Chem       Date:  2007-09-06

10.  Sphingosine-1-phosphate receptor-independent lung endothelial cell barrier disruption induced by FTY720 regioisomers.

Authors:  Sara M Camp; Alexander Marciniak; Eddie T Chiang; Alexander N Garcia; Robert Bittman; Robin Polt; Ruth G Perez; Steven M Dudek; Joe G N Garcia
Journal:  Pulm Circ       Date:  2020-02-10       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.